8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Intravitreal anti-vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta-analysis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To conduct a systematic review with network meta-analysis (NMA) of randomized clinical trials (RCTs) comparing panretinal photocoagulation (PRP) versus anti-vascular endothelial growth factor (VEGF) treatment alone or in combination with PRP, for proliferative diabetic retinopathy (PDR).

          Related collections

          Author and article information

          Journal
          Acta Ophthalmol
          Acta ophthalmologica
          Wiley
          1755-3768
          1755-375X
          Sep 2021
          : 99
          : 6
          Affiliations
          [1 ] Department of Ophthalmology, University of Catania, Catania, Italy.
          [2 ] Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, Catania, Italy.
          [3 ] Faculty of Medicine, University of Southampton, Southampton, UK.
          [4 ] Department of Experimental Biomedicine and Clinical Neuroscience, Ophthalmology Section, University of Palermo, Palermo, Italy.
          [5 ] Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
          [6 ] Department of Ophthalmology, University of Bari, Bari, Italy.
          [7 ] Department of Public Health, University of Naples Federico II, Naples, Italy.
          [8 ] Department of Surgical Sciences, Eye Clinic Section, University of Turin, Turin, Italy.
          Article
          10.1111/aos.14681
          33326183
          67fb7ff8-d2a2-4382-8db4-afc67de2688d
          History

          ranibizumab,bevacizumab,intravitreal anti-VEGF,panretinal photocoagulation,pegaptanib,proliferative diabetic retinopathy,aflibercept

          Comments

          Comment on this article